SRS Capital Advisors »

Celldex Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Celldex Therapeutics

Jun 302024Jul 14Jul 28Aug 11Aug 25Sep 8Sep 2247004800490050005100138138.5139139.5140
Value ($)Share countHistorical CLDX position of SRS Capital Advisors Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.7k 139 33.99
2024-06-30 $5.1k 139 37.01